\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesThe European Commission organises an online event on the Digital Decade Report 2024: Setting the scene for the new EU's digital policy agenda.
The event aims to discuss the progress made toward the vision of the Digital Decade through 2030, in the context of the priorities for 2024-2029 as presented by Commission president Von der Leyen.
The objective of this panel is to show how the State of the Digital Decade 2024 Report aligns with the momentum raised by this year’s input, proposals and conversations around the Draghi and Letta Reports.
More information on the event and the possibility to register can be found on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
